Kamada Ltd.
Develops specialty plasma-derived therapeutics for rare and serious conditions.
KMDA | TA
Overview
Corporate Details
- ISIN(s):
- IL0010941198
- LEI:
- Country:
- Israel
- Address:
- 2 Holzman St, Science Park, 7670402 Rehovot
- Website:
- https://www.kamada.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Kamada Ltd. is a vertically integrated global biopharmaceutical company focused on specialty plasma-derived therapeutics. The company develops, produces, and markets a portfolio of pharmaceuticals for rare and serious conditions, utilizing a proprietary platform technology for the extraction and purification of proteins from human plasma. Its key therapeutic areas include Alpha-1 Antitrypsin Deficiency (AATD), rabies prophylaxis, and prevention of cytomegalovirus (CMV) in transplant recipients. Kamada maintains a diverse portfolio of marketed products and a robust development pipeline, supported by industry-leading manufacturing and protein separation capabilities.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-02 16:03 |
Foreign Filer Report
Kamada to Participate in Upcoming September Investor Conferences
|
English | 135.5 KB | ||
| 2025-09-02 16:03 |
Foreign Filer Report
Kamada to Participate in Upcoming September Investor Conferences
|
English | 36.3 KB | ||
| 2025-08-13 16:00 |
Foreign Filer Report
Second Quarter and First Half 2025 Financial Results
|
English | 4.1 MB | ||
| 2025-08-13 16:00 |
Foreign Filer Report
Second Quarter and First Half 2025 Financial Results
|
English | 36.8 KB | ||
| 2025-08-11 16:00 |
Foreign Filer Report
FDA Approval of its Plasma Collection Center in Houston, Texas
|
English | 184.4 KB | ||
| 2025-08-11 16:00 |
Report Publication Announcement
FDA Approval of its Plasma Collection Center in Houston, Texas
|
English | 36.5 KB | ||
| 2025-08-06 16:05 |
Foreign Filer Report
to Announce Second Quarter and First Half Ended June 30, 2025, Financial Result…
|
English | 155.6 KB | ||
| 2025-08-06 16:05 |
Foreign Filer Report
to Announce Second Quarter and First Half Ended June 30, 2025, Financial Result…
|
English | 36.5 KB | ||
| 2025-08-05 17:33 |
Regulatory News Service
Due to an error, trade halt was initiated in KAMADA's shares instead of CAMTEK'…
|
Hebrew (modern) | 62.0 KB | ||
| 2025-06-17 16:00 |
Foreign Filer Report
Kamada Confirms Continuous Global Business Operations and Products Availability…
|
English | 134.2 KB | ||
| 2025-06-17 16:00 |
Regulatory News Service
Kamada Confirms Continuous Global Business Operations and Products Availability…
|
English | 36.6 KB | ||
| 2025-05-14 16:00 |
Foreign Filer Report
Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year …
|
English | 8.4 MB | ||
| 2025-05-14 16:00 |
Earnings Release
Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year …
|
English | 36.5 KB | ||
| 2025-05-07 16:00 |
Foreign Filer Report
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
|
English | 151.4 KB | ||
| 2025-05-07 16:00 |
Report Publication Announcement
Kamada to Announce First Quarter 2025 Financial Results on May 14, 2025
|
English | 36.3 KB |
Automate Your Workflow. Get a real-time feed of all Kamada Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Kamada Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
